Content validity of the female sexual function index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorder

Journal of Sexual Medicine

Volumn 8, Issue 8, 2011, Pages 2237-2245

  Revicki, Dennis A ^a   Margolis, Mary K ^a   Bush, Elizabeth N ^a   Derogatis, Leonard R ^b   Hanes, Vladimir ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Female Sexual Function Index; FSFI; HSDD; Hypoactive Sexual Desire Disorder; Patient Reported Outcome; PRO; Validation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTENT VALIDITY; DISTRESS SYNDROME; EMOTIONAL STRESS; FEMALE; FEMALE SEXUAL FUNCTION INDEX; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INTERVIEW; PERCEPTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; SEXUAL BEHAVIOR;

EID: 79960840742     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02312.x     Document Type: Article

References (25)

1. Hatzichristou D, Rosen RC, Derogatis LR, Low WY, Meuleman EF, Sadovsky R, Symond T. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 2010;7:337-48.
2. Clayton AH, Dennerstein L, Fisher WA, Kingsberg SA, Perelman MA, Pyke RE. Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment. J Sex Med 2010;7:541-60.
3. DeRogatis LR. Assessment of sexual function/dysfunction via patient reported outcomes. Int J Impot Res 2008;20:35-44.
4. Kingsberg S, Althof SE. Evaluation and treatment of female sexual disorders. Int Urogynecol J Pelvic Floor Dysfunct 2009;20(1 suppl):S33-43.
5. Food and Drug Administration (FDA). Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims. Fed Regist 2009;74:65132-3.
6. Sand M, Rosen R, Meston C, Brotto L. The Female Sexual Function Index (FSFI): A potential "gold standard" measure for assessing therapeutically-induced change in female sexual function. Fertil Steril 2009;2:129.
7. Rosen RC, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agosino R. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
8. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 2003;29:39-46.
9. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.
10. Gerstenberger EP, Rosen RC, Brewer JV, Meston CM, Brotto LA, Wiegel M, Sand M. Sexual Desire and the Female Sexual Function Index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without Hypoactive Sexual Desire Disorder. J Sex Med 2010;7:3096-103.
11. American Psychiatric Association. DSM-IV: Diagnostic and statistical manual of mental disorders, 4th edition. Text revision. Washington DC: American Psychiatric Press; 2000.
12. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: Prevalence and correlates. Obstet Gynecol 2008;112:970-8.
13. Biddle AK, West SL, D'Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive Sexual Desire Disorder in postmenopausal women: Quality of life and health burden. Value Health 2009;12:763-72.
14. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive Sexual Desire Disorder in menopausal women: A survey of Western European women. J Sex Med 2006;3:212-22.
15. Graziottin A, Koochaki PE, Rodenberg CA, Dennerstein L. The prevalence of hypoactive sexual desire disorder in surgically menopausal women: An epidemiological study of women in four European countries. J Sex Med 2009;6:2143-53.
16. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46-56.
17. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009;6:1549-60.
18. DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008;5:357-64.
19. Clayton AH, Goldfischer ER, Goldstein I, Derogatis L, Lewis-D'Agostino DJ, Pyke R. Validation of the Decreased Sexual Desire Screener (DSDS): A brief diagnostic instrument for generalized acquired female Hypoactive Sexual Desire Disorder (HSDD). J Sex Med 2009;6:730-8.
20. Creswell JW. Qualitative inquiry and research design: Choosing among five methods. Thousand Oaks, CA: Sage; 1998.
21. Fisher WA, Eardley I, Fuchs M, Sand M. The DESIRE (Desire and its Effects on female Sexuality Including RElationships) Study: Emotional impact of low sexual desire and associated distress in a sample of 5, 089 European women. J Sex Med 2010;7:128.
22. Revicki D, Fisher W, Rosen R, Kuppermann M, Margolis MK, Hanes V. The impact of Hypoactive Sexual Desire Disorder (HSDD) on women and their relationships: Qualitative data from patient focus groups. J Sex Med 2010;7:124-5.
23. Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: Developing best practices based on science and experience. Qual Life Res 2009;18:1263-78.
24. Leidy NK, Vernon M. Perspectives on patient-reported outcomes: Content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 2008;26:363-70.
25. Willis G. Cognitive interviewing. Thousand Oaks, CA: Sage; 2005.